SI-BONE, Inc. (SIBN)
Market Cap | 762.23M |
Revenue (ttm) | 131.98M |
Net Income (ttm) | -43.53M |
Shares Out | 40.50M |
EPS (ttm) | -1.19 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 395,325 |
Open | 18.94 |
Previous Close | 18.96 |
Day's Range | 18.32 - 19.08 |
52-Week Range | 11.23 - 29.51 |
Beta | 0.99 |
Analysts | Strong Buy |
Price Target | 26.57 (+41.18%) |
Earnings Date | Nov 6, 2023 |
About SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ,... [Read more]
Financial Performance
In 2022, SI-BONE's revenue was $106.41 million, an increase of 18.03% compared to the previous year's $90.15 million. Losses were -$61.26 million, 8.28% more than in 2021.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for SIBN stock is "Strong Buy." The 12-month stock price forecast is $26.57, which is an increase of 41.18% from the latest price.
News

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
Annual guidance increased to $136 million - $137 million, implying annual growth of 28%-29% Annual guidance increased to $136 million - $137 million, implying annual growth of 28%-29%

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods
SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that cert...

SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023
SANTA CLARA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance
Annual guidance increased to $132 million - $134 million, implying annual growth of 24%-26% Annual guidance increased to $132 million - $134 million, implying annual growth of 24%-26%

SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023
SANTA CLARA, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023
SANTA CLARA, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023
SANTA CLARA, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced ...

SI-BONE Announces Pricing of Public Offering of Common Stock
SANTA CLARA, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced ...

SI-BONE Announces Launch of Public Offering of Common Stock
SANTA CLARA, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced ...

SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual Guidance
Annual guidance increased to $128 million - $131 million, implying annual growth of 20%-23% Annual guidance increased to $128 million - $131 million, implying annual growth of 20%-23%

SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference
SANTA CLARA, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce...

SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023
SANTA CLARA, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce...

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance
SANTA CLARA, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported f...

SI-BONE To Report Fourth Quarter 2022 Financial Results on February 27, 2023
SANTA CLARA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022
Fourth Quarter revenue of $31.7 - $31.9 million representing growth of approximately 26% Fiscal Year 2022 revenue of $106.1 - $106.3 million representing growth of approximately 18%

SI-BONE to Host a Virtual Fireside Chat at the 25th Annual Needham Growth Conference
SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite® Implant System
New Indications Include Use with a Broad Class of Commercially Available Rods New Indications Include Use with a Broad Class of Commercially Available Rods

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2022 and Updates Guidance
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported f...

SI-BONE To Report Third Quarter 2022 Financial Results on November 7, 2022
SANTA CLARA, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare Conference
SANTA CLARA, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022
SANTA CLARA, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported f...

SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022
SANTA CLARA, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...